Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H60N4O9 |
InChIKeyXEMRMMAFXLINDA-XVCXXHFGSA-N |
CAS Registry1225383-40-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | 25 Jan 2019 |